LIC raises stake in Dr. Reddy’s
The Hindu
LIC increases stake in Dr. Reddy's Labs to over 8%, acquiring more than 2% since October 2024.
Life Insurance Corporation of India’s stake in Dr. Reddy’s Laboratories raced past the 8% mark recently with the country’s largest institutional investor acquiring an additional, more than 2% in the generic drugmaker since October 2024.
From about 6.20%, the holding increased to 8.21% in a period of less than eight months through open market purchases. In terms of number of shares, LIC had acquired more than 1.67 crore during this period, the Hyderabad-headquartered pharma major said in a filing.
Dr. Reddy’s shares closed 3.01% higher on Thursday at ₹1,289.90 apiece on the BSE.

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












